Molecular signature-based decision making in the era of targeted therapies for systemic lupus erythematosus. (January 2023)

Record Type:: Journal Article
Title:: Molecular signature-based decision making in the era of targeted therapies for systemic lupus erythematosus. (January 2023)
Main Title:: Molecular signature-based decision making in the era of targeted therapies for systemic lupus erythematosus
Authors:: Parodis, Ioannis
Abstract:
Is Part Of:: Lancet. Volume 5:Number 1(2023)
Journal:: Lancet
Issue:: Volume 5:Number 1(2023)
Issue Display:: Volume 5, Issue 1 (2023)
Year:: 2023
Volume:: 5
Issue:: 1
Issue Sort Value:: 2023-0005-0001-0000
Page Start:: e4
Page End:: e6
Publication Date:: 2023-01
Subjects:: Rheumatology -- periodicals
616.72305
Journal URLs:: https://www.thelancet.com/journals/lanrhe/issues#decade=loi_decade_201 ↗
https://www.sciencedirect.com/journal/the-lancet-rheumatology ↗
http://www.sciencedirect.com/ ↗
DOI:: 10.1016/S2665-9913(22)00358-7 ↗
Languages:: English
ISSNs:: 2665-9913
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 24817.xml